Transcript Highlights:

• By way of background, psilocybin is a naturally occurring psychoactive chemical compound produced in
• Psilocybin is a naturally occurring psychoactive chemical compound produced in some species of mushrooms
• Department of Health, including drug cost payment amounts received for 340B drugs, payments made to pharmacies

Bills: SB5921, SB5185, SB6182, SB6115, SB6258, SB5916, SB5981, SB5985, SB6019, SB6161, SB6183

Keywords: psilocybin, mental health, therapy, decriminalization, legalization, international medical graduates, preceptorship, hardship pathways, medical practice, licensure, abortion, reproductive health, pregnancy termination, clinic access, abortion access fund, abortion savings account, health carrier assessment, insurance assessment, health insurer tax, Department of Health

Transcript Highlights:

• Senator Weaver, you are recognized for your nominee to serve on the State Board of Pharmacy.
• Her father, John Lasters, who is here with us, has not only been a mainstay in the pharmacy community
• Our executive director of the State Board of Pharmacy, Mr. Marty Hendrick, is here in support.
• That are have started clinical trials on ibogien-like compounds.
• Pharmacy law didn't clearly recognize them as licensed practitioners in the same way.

Bills: HB3767, HB3934, HB4199, HB4336, HB2947, HB3834, HB4302, HB4095, HB3287, HB3649, HB4430, HB4431, HB2059, HB3647

Keywords: controlled dangerous substances, controlled substances, drug scheduling, Schedule I, Schedule IV, anti-drug diversion, drug diversion, synthetic opioids, fentanyl analogs, designer drugs, synthetic cannabinoids, benzodiazepines, benzodiazepine analogs, opioids, hallucinogens, depressants, pharmacy regulation, narcotics control, Oklahoma State Bureau of Narcotics and Dangerous Drugs Control, DEA scheduling

Transcript Highlights:

• Her father, John Laster, who's here with us, has not only been a mainstay in the pharmacy community for
• And our executive director, the State Board of Pharmacy, Mr. Marty Hendrick, is here in support.
• PBMs play a big part in that with the payment of pharmacy and how the health care system is done.
• Essentially, ibogaine is a psychoactive compound derived from the iboga plant in West Africa.
• Ibogaine is a psychoactive compound derived from the iboga plant in Equatorial West Africa.

Bills: HB3767, HB3934, HB4199, HB4336, HB2947, HB3834, HB4302, HB4095, HB3287, HB3649, HB4430, HB4431, HB2059, HB3647

Keywords: controlled dangerous substances, controlled substances, drug scheduling, Schedule I, Schedule IV, anti-drug diversion, drug diversion, synthetic opioids, fentanyl analogs, designer drugs, synthetic cannabinoids, benzodiazepines, benzodiazepine analogs, opioids, hallucinogens, depressants, pharmacy regulation, narcotics control, Oklahoma State Bureau of Narcotics and Dangerous Drugs Control, DEA scheduling

Summary: The Senate Health and Human Services Committee first considered three executive nominations. Shonda Lasseter was reappointed to the State Board of Pharmacy, with discussion focused on pharmacy staffing shortages, PBMs, and broader health care workforce challenges; she was advanced 11-0. Dr. Lane Sabara was renominated to the Health Care Workforce Training Commission, where members discussed rural physician shortages and training pipelines; he was advanced 12-0. Dr. Paul Wright was nominated to fill an unexpired term on the same commission and was advanced 12-0 after questions about his availability and experience supporting rural medicine. The committee then heard several health-related bills. HB 3767, which adds 14 chemicals used to enhance fentanyl to Oklahoma’s controlled substances schedules, advanced 10-0. HB 3934, a dentistry workforce and cleanup bill updating insurance-claim and billing language, advanced 11-0. HB 4199, creating a three-year tri-share workforce pilot program for the Department of Commerce, was amended to change eligibility language and then advanced 9-2. HB 2947, allowing supervised behavioral health interns to bill Medicaid, advanced 10-1. HB 3834, authorizing the Department of Health to begin stage-one clinical trials for ibogaine and creating a revolving fund for that purpose, drew extensive testimony about veteran and first responder treatment, safety, funding, and state liability, and advanced 10-2. Additional measures also moved forward. HB 4302, after amendment, advanced 12-0 on a juvenile oversight reporting and law enforcement notification issue. Committee member bills included HB 495, reinstating the 211 Collaborative advisory council, which advanced 11-0; HB 3287, requiring domestic violence and human trafficking signage in health facilities, which advanced 11-0; HB 3649, allowing the Mental Health Department to sell underused property and keep the proceeds in its trust, which advanced 12-0 after amendment; HB 4430, clarifying malpractice coverage for APRNs and PAs at state facilities, which advanced 12-0; HB 2059, creating a mechanism to reimburse medication costs for incarcerated people in county and municipal jails, which advanced 12-0 after questions about continuity of care; and HB 3647, creating an all-payer claims database and transparency board, which advanced 10-2. The committee adjourned after announcing another meeting the following week.

Transcript Highlights:

• Whole Health Pharmacy is an independent community pharmacy that serves as a 340B contract pharmacy for
• We're now in a pharmacy desert, with all of these pharmacies.
• pharmacies shut down.
• What we got from the contract pharmacy and retail pharmacy benefits...
• What we got from the contract pharmacy and retail pharmacy benefits was only $318 million.

Bills: SB5904, SB5915, SB6025, SB5933, SB5990, SB5981

Keywords: nursing titles, licensure, healthcare professionals, patient safety, professional standards, SB 5915, health technology assessment, HTA, clinical committee, medical technology review, coverage determination, state-purchased health care, Washington health care, RCW, evidence-based medicine, cost-effectiveness, safety and efficacy, Medicare coverage, national coverage determination, clinical guidelines

Transcript Highlights:

• The bill would require the State Board of Pharmacy to adopt rules to this effect.
• Chair, I’m happy to take any questions, and we do have an invited witness and the State Board of Pharmacy
• And we know how bad opioids are because we have the pharmacies tracking them, but because people get
• And they’re not going to go away because opioids are a big moneymaker for the pharmacies.
• with pharmacists in other states, and found that many states already have this law in their state pharmacy

Bills: HB136, HB451, SB425, SB466, SB905, SB1986, SB2311, SB2450, SB2805, SB2826, SB2919, SB3001

Keywords: Medicaid, lactation, healthcare, consultation, reimbursement, maternal health, infant care, commercial sexual exploitation, child sex trafficking, human trafficking, child welfare, foster care, DFPS, Department of Family and Protective Services, juvenile probation, risk assessment, needs assessment, trauma screening, child abuse prevention, exploitation screening

Summary: The committee met with a quorum and announced it would vote on pending bills at 10:30, with public testimony limited to two minutes. It first took up Senate Bill 905, a TDLR cleanup bill on licensing regulation of speech-language pathologists and audiologists. Senator Zafferini said the committee substitute would streamline advisory board consultation, remove obsolete provisional licenses, and allow any licensed physician to authorize hearing instruments for minors; the substitute was adopted and the bill left pending. The committee then heard House Bill 451, which would require universal screening for commercial sexual exploitation risk for children in DFPS conservatorship and youth under TJJD jurisdiction. The author and witnesses from Children at Risk, the Fort Bend Anti-Trafficking Collective, and Texas CASA supported the bill as a prevention tool with existing infrastructure and training; the committee adopted the substitute and left the bill pending. The committee next considered Senate Bill 466, which would clarify that families may request a fetal death certificate at any gestational age, while keeping existing filing requirements for physicians. A constituent father testified about losing his 11-week-old daughter and being told he could not obtain a certificate, which he said prevented funeral arrangements; the substitute was adopted and the bill left pending. Senate Bill 2311 followed, requiring residential treatment centers to have a written agreement with the school that will educate resident children before becoming operational. The author cited a local dispute where an RTC and school district lacked communication, and witnesses from Texas CASA and Disability Rights Texas supported clearer educational planning while suggesting the Education Code may need conforming changes; the bill was left pending. The committee then heard Senate Bill 2826, known as Alyssa’s Law, which would create a statewide education program on medical child abuse for medical students, health care professionals, and CPS caseworkers. The author and Sheriff Bill Weyburn described Alyssa’s case as involving repeated unnecessary surgeries and argued the bill would improve awareness and early identification, while several witnesses and members raised concerns about false accusations, impacts on medically fragile children, and the need for scientific, peer-reviewed training and safeguards. After extensive discussion, the chair left the bill pending. The committee also heard House Bill 136, which would add certified lactation consultants as Medicaid providers to expand breastfeeding support; witnesses from lactation and nutrition fields said the bill would improve access, maternal and infant health, and long-term savings, and the bill was left pending. Finally, the committee took up Senate Bill 2805, a surprise-billing/arbitration measure that would clarify provider identifiers and shift arbitration costs to the losing party. The author said the substitute was a legislative counsel draft with no substantive difference, and witnesses from the Texas Medical Association, Texas Society of Anesthesiologists, and U.S. Anesthesia Partners supported the bill as a modest improvement that would reduce administrative confusion and make arbitration fairer without weakening patient protections. Members discussed how arbitration costs affect settlement behavior and how to define the “winner” in close cases. The bill was heard but not voted out during this segment.

Transcript Highlights:

• . assist and pharmacies.
• Contract pharmacy protections.
• Well, not the pharmacy.
• In Texas, we're now seeing the closure of one hundred pharmacies. on pharmacy every week.
• Pharmacy, so they are the middleman who pays the pharmacies.

Bills: HB712, HB722, HB946, HB1687, HB1809, HB1899, HB2528, HB2583, HB2741, HB2750, HB3021, HB3150, HB3265, HB3658, HB3812, HB3960, HB4392, HB4432

Keywords: prostate cancer, health benefit plans, insurance coverage, cost sharing, preventive health care, auto insurance, total loss evaluation, disclosure, insurance materials, vehicle appraisal, HB 946, Texas Insurance Code, automobile insurance claims, oral release, written release, settlement agreement, claim release, property damage, bodily injury, psychological injury

Bills: HB712, HB722, HB946, HB1687, HB1809, HB1899, HB2528, HB2583, HB2741, HB2750, HB3021, HB3150, HB3265, HB3658, HB3812, HB3960, HB4392, HB4432

Keywords: prostate cancer, health benefit plans, insurance coverage, cost sharing, preventive health care, auto insurance, total loss evaluation, disclosure, insurance materials, vehicle appraisal, HB 946, Texas Insurance Code, automobile insurance claims, oral release, written release, settlement agreement, claim release, property damage, bodily injury, psychological injury

Transcript Highlights:

• And that line of case law started in 1976 with the Virginia Pharmacy Board case, and some of the advertising
• owners navigating their pets' medical concerns by providing flexibility to pick up medicine at the pharmacy
• transparency by letting pet owners understand their right to receive a written prescription and shop at the pharmacy

Bills: S0408, S0986, S0678, S0800, S1050, S0484, S1118

Keywords: vaccine advertisement, manufacturer liability, harmful vaccine, healthcare, court action, smoking regulation, public health, vaping, marijuana, public places, Florida Statutes, alcohol distribution, tax deductions, extraordinary losses, warehouse breakage, regulatory compliance, veterinary, prescription, pharmacy, client rights

Summary: The Committee on Regulated Industries considered several bills and took final action on each. SB 986, by Senator Gruters and presented by Senator Rodriguez, would prohibit smoking or vaping marijuana in public places and in certain indoor spaces; restaurant and lodging representatives supported adding marijuana and vaping to clean indoor air rules but asked to preserve designated smoking areas on private property, while cannabis advocates warned the bill was overly broad and could affect patients and property rights. The committee voted the bill favorably. SB 678, by Senator Mayfield, would restore statutory authority for DBPR to continue allowing alcohol distributors to deduct unsellable alcohol from monthly excise tax calculations; the committee adopted a strike-all amendment and reported the committee substitute favorably. SB 800, also by Senator Mayfield, increases penalties for repeated unlicensed engineering practice and creates an engineering student loan assistance program for engineers working for state agencies and water management districts; after adopting an amendment clarifying eligibility, the committee reported the bill favorably. The committee then heard SB 408, by Senator Grall, which would create a Florida cause of action against vaccine manufacturers that advertise in the state, allowing injured individuals to sue in Florida courts. Supporters argued the bill would rebuild public trust and hold manufacturers accountable, while opponents from the Florida Justice Reform Institute, American Tort Reform Association, BIO, the U.S. Chamber Institute for Legal Reform, and several medical and business groups argued the field is largely preempted by federal law, that existing federal compensation programs already address vaccine injuries, and that the bill raises First Amendment and policy concerns. After debate focused on vaccine injury data, compensation rates, and liability, the committee voted SB 408 favorably. The committee also considered SB 484 and SB 1118, both by Senator Avila, dealing with data centers. SB 484 would preserve local planning authority, bar nondisclosure agreements that prevent disclosure of potential data center development, require the PSC to set large-load tariff requirements so data centers pay their own costs, and limit consumptive use permits for large-scale data centers absent no harm to water resources and compliance with local zoning; supporters emphasized ratepayer protection and economic development, while some witnesses urged flexibility for behind-the-meter projects and confidentiality in negotiations. The bill was reported favorably. SB 1118 would create a time-limited public records exemption for county or municipal information about data center siting and protect proprietary business information; Senator Pizzo raised concerns about how the exemption would affect disclosure of competing projects and local officials’ ability to speak, but the sponsor said he would work on clarifying the language. The committee also passed SB 1050, by Senator Calatayud, which requires veterinarians to provide pet owners with written prescriptions and information about pharmacy choice while preserving veterinary judgment and emergency dispensing authority. The meeting concluded after all bills were reported favorably and members recorded additional votes on prior items.

Transcript Highlights:

• And that line of case law started in 1976 with the Virginia Pharmacy Board case, and some of the advertising
• owners navigating their pets' medical concerns by providing flexibility to pick up medicine at the pharmacy
• transparency by letting pet owners understand their right to receive a written prescription and shop at the pharmacy

Bills: S0408, S0986, S0678, S0800, S1050, S0484, S1118

Keywords: vaccine advertisement, manufacturer liability, harmful vaccine, healthcare, court action, smoking regulation, public health, vaping, marijuana, public places, Florida Statutes, alcohol distribution, tax deductions, extraordinary losses, warehouse breakage, regulatory compliance, veterinary, prescription, pharmacy, client rights

Transcript Highlights:

• Every time you call the pharmacy, they say, 'Hey, will you agree to do the generic version?'
• The prescription drug program was designed to expand the number of pharmacy locations in Texas where
• Members, the Texas State Board of Pharmacy, referred to as the BOP, was initially designated to implement
• It also removes the cap on the number of participating chain pharmacies, expanding participation in the
• over-the-counter prescription drugs to be collected and streamlines the application. process for pharmacies

Bills: SB128, SB640, SB672, SB904, SB1141, SB1263, SB1525, SB1528, SB2041, SB2306, SB2308, SB2357, SB2446, SB2695, SB2857, SB2891, SB2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, SB 640, Texas Family Code, Department of Family and Protective Services, DFPS, child welfare, foster care, managing conservatorship, suicide attempt, youth suicide, mental health, child protective services, state custody, annual report, reporting requirements

Transcript Highlights:

• to explore. alternatives grounded in science that are focused on recovery. a naturally-occurring compound
• successful clinical trial the way in which we handhold, so to speak, the administration of this compound
• So ibogaine is the only compound that we know of that can actually be given to somebody when they're
• become available as either an over the countable an over the countable or dispensed through the pharmacy
• So one thing we know about ibogaine too is it's a class of compounds that are called cycloplastogens.

Bills: SB128, SB640, SB672, SB904, SB1141, SB1263, SB1525, SB1528, SB2041, SB2306, SB2308, SB2357, SB2446, SB2695, SB2857, SB2891, SB2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, SB 640, Texas Family Code, Department of Family and Protective Services, DFPS, child welfare, foster care, managing conservatorship, suicide attempt, youth suicide, mental health, child protective services, state custody, annual report, reporting requirements

Transcript Highlights:

• However, excessively stringent Board of Pharmacy regulations for compounding pharmacies have shrunk the
• number of California veterinary compounding pharmacies to just a few, and those pharmacies are disincentivized
• “Ten years ago, we had over 100 compounding pharmacies throughout California.
• The Board of Pharmacy has systematically targeted compounding pharmacies and restricted access to key
• Just a few years ago, dozens of pharmacies safely compounded glutathione.

Summary: The joint Assembly and Senate business committees held a sunset review hearing on the California State Board of Pharmacy, with board leadership describing the board’s consumer-protection role and its priorities around access, enforcement, and updating pharmacy law. The board emphasized a proposed shift toward a standard-of-care model for pharmacists, arguing it would reduce rigid protocol requirements and improve access to services such as HIV PrEP/PEP, contraception, and naloxone. Board representatives also discussed pharmacy deserts, possible fee waivers for pharmacies in underserved areas, concerns about payer practices contributing to closures, continuing education audits, and a request to restore more flexibility in licensure decisions and probationary monitoring for applicants with certain criminal histories. A major focus of the hearing was the board’s ongoing compounding regulations, especially the treatment of sterile versus nonsterile compounding and substances such as glutathione and methylcobalamin. The board said the proposal was not a ban on those substances and described the rulemaking as grounded in federal law, USP standards, and public comment, noting the process had gone through multiple modified texts and hearings. Testimony from stakeholders was sharply divided: pharmacists, veterinarians, firefighters, naturopathic doctors, and patient advocates warned the rules were restricting access to compounded medications and harming patients and first responders, while the California Medical Association, psychiatric physicians, and PhRMA raised concerns that the board’s proposals could expand pharmacist authority beyond training, affect physician practice, or create safety risks. Other public comments addressed pharmacy technician ratios, remote processing, flavoring medications, hospital-specific regulation, budget and enforcement transparency, and whether the board should add members with community compounding or pharmacy technician expertise. Committee members also asked about the board’s oversight priorities and the rationale for its standard-of-care proposal. Board staff explained that consumer protection includes education, licensing, policy, and enforcement, with the highest-priority enforcement cases being those posing imminent public harm. After public testimony concluded, the chairs thanked participants and adjourned the sunset review hearing, announcing an immediate transition to the joint informational hearing on the Department of Cannabis Control.

Transcript Highlights:

• Pharmacies that are making these compounded drugs today. Thank you. Thank you. Next speaker, Mr.
• all over the country, said the compounding pharmacy must maintain vendor files to document licensing
• To state legislators all over the country said the compounding pharmacy must maintain vendor files to
• Do you compound beforehand before someone comes to your pharmacy, or how does that work? So, Mr.
• HB 4036 makes several incorrect claims about compounding pharmacy regulation as it applies to Arizona

Summary: The committee began with a presentation from Berthold Barak Karlich of Benor Capital on investment and innovation from a European perspective. He argued that legacy in trade and innovation is about enabling future generations, not isolation, and highlighted Austria and Europe’s strengths in education, applied research, hidden-champion SMEs, and deep-tech. He also warned against economic nationalism and emphasized that entrepreneurship and cross-border trade create shared interests, peace, and long-term collaboration. In response to questions, he said Arizona had impressed him as a strong, international deep-tech hub, and he expressed interest in learning more about opportunities there. The committee then considered HB 2746, which creates a study committee on trade offices under the Arizona Commerce Authority to review existing trade offices, gather stakeholder input, and report recommendations by December 31, 2028. Members discussed oversight of Arizona’s trade offices in countries including Mexico, Korea, Taiwan, Japan, Romania, and Germany, and the sponsor said the bill would help evaluate effectiveness while identifying new opportunities. The bill received a due pass recommendation on a 7-0 vote. HB 2750, which establishes the Arizona-Sonora Trade Commission with legislative appointees, also received a due pass recommendation after members discussed its role as a complement to executive-branch efforts; it passed 5-1 with one present. The committee next heard HB 4036, a bill restricting the sale and distribution of compounded GLP-1 weight-loss drugs made with certain bulk drug substances and authorizing inspections by the State Board of Pharmacy. Supporters, including Novo Nordisk and the Partnership for Safe Medicines, argued the bill would address unsafe imported ingredients, impurities, misleading advertising, and a surge in mass compounding that they said exceeds the intent of compounding law. Opponents from the Arizona Pharmacy Association, compounding pharmacists, and a physician argued the bill would burden lawful compounders, raise costs, reduce access, and could harm patients who rely on compounded medications. After extensive debate, the committee failed to pass HB 4036 on a 5-5 vote. Finally, the committee took up HB 2765, as amended by a strike-everything amendment creating a vapor product manufacturer licensing framework, fees, penalties, and Department of Revenue oversight. The sponsor said the measure was intended to address illegal smuggling of vape products and protect children, while opponents argued it would burden lawful businesses and that the real problem was illicit actors outside the regulated market. The transcript ends during the discussion of this bill, before a final vote is recorded.

Transcript Highlights:

• AB 1990 protects patients by increasing regulatory standards for compounded pharmacies who produce GLP
• I support AB 1990 because of compounding pharmacies like Empower Pharmacy in Houston, Texas.
• Compounding pharmacies are required to follow rigorous U.S.P standards and are overseen by the California
• There was a pharmacy that compounded. Now we just have sort of big brand pharmacy.
• There was a pharmacy that compounded. Now we just have sort of big brand pharmacy.

Keywords: 988, house, all

Transcript Highlights:

• AB 1990 protects patients by increasing regulatory standards for compounded pharmacies that produce GLP
• I support AB 1990 because of compounding pharmacies like Empower Pharmacy in Houston, Texas.
• Compounding pharmacies are required to follow rigorous U.S.P. standards and are overseen by the California
• There was a pharmacy that compounded. Now we just have sort of big-brand pharmacy.
• pharmacy.

Summary: The Assembly Business and Professions Committee heard a long agenda of bills, with several cannabis-related measures drawing the most testimony. AB 1598 would extend and standardize licensing timelines for behavioral health professionals, AB 1850 would clarify that real estate wholesalers are subject to licensure and disclosure rules, AB 1794 would allow enteral formula to be shipped directly to patients’ homes, and AB 2402 would update an old cap on fees for multi-service health club studios. The committee also heard AB 1990 on compounded GLP-1 drugs, AB 2249 on cannabis packaging attractive to children, AB 2532 on cannabis beverage serving sizes, AB 2537 on prioritizing cannabis enforcement, and AB 1826 on due process protections for cannabis businesses facing embargoes or recalls. Testimony was generally split between public health or consumer-protection advocates and industry representatives. Supporters of the cannabis bills argued for clearer rules, better consumer safety, and more predictable enforcement, while opponents warned that some proposals could overreach, burden compliant businesses, or restrict legitimate branding and access. On AB 1990, supporters said compounded GLP-1 products need stronger testing and truthful advertising, while pharmacists and compounding advocates said existing law already covers much of the conduct and that the bill could create access problems. On AB 2249 and AB 2532, public health witnesses emphasized risks to children and accidental overconsumption, while industry groups sought narrower language and more implementation time. The committee took several roll-call votes after quorum was established. AB 2249, AB 1826, AB 2402, AB 1794, and AB 2532 were all approved and sent to Appropriations, and AB 1826 was sent to Judiciary. The chair and members repeatedly noted accepted committee amendments and, in several cases, said they were prepared to support the bills with those amendments. Some measures were left open or held pending further action as the hearing continued.

Transcript Highlights:

• She's here on behalf of the Alliance of Pharmacy Compounding, and she's a licensed pharmacist as well
• She's here on behalf of the Alliance of Pharmacy Compounding, and she's a licensed pharmacist as well
• By the way, we don't have very many compound pharmacies left in California, very few.
• APC is the national trade association for compounding pharmacies, representing more than 600 compounding
• APC is the National Trade Association for Compounding Pharmacy. sterile compounding pharmacist.

Keywords: 987, senate, all

Transcript Highlights:

• She's here on behalf of the Alliance of Pharmacy Compounding, and she's a licensed pharmacist as well
• I'm a licensed pharmacist and former owner of Pacific Compounding Pharmacy in Stockton, where I served
• By the way, we don't have very many compound pharmacies left in California, very few.
• My name is Teneal Davis, and I'm the Chief Advocacy Officer for the Alliance for Pharmacy Compounding
• APC is the national trade association for compounding pharmacy.

Summary: The committee heard several bills, beginning with AB 1921 on video game shutdowns. The author and Consumer Reports supported requiring game operators to give 60 days’ notice before ending server support and to offer a menu of remedies, including refunds or playable/offline alternatives, while the Entertainment Software Association opposed the bill as an unwarranted new standard for digital products and raised safety and legal concerns about community servers. Members questioned the scope of refunds, copyright, and community-server issues, and the author said he was open to further amendments. The bill was moved on a due-pass motion to Senate Appropriations and placed on call. AB 1965, dealing with cannabis testing, was presented as a measure to strengthen the Department of Cannabis Control’s authority over testing labs and improve product safety and transparency. The California Cannabis Operators Association supported the bill, saying it would help ensure consistent standards and protect consumers in a market with a large illicit component. There was no opposition, and the bill was moved on a due-pass motion to Senate Appropriations and placed on call. The committee also heard AB 2141, which would allow the Board of Pharmacy to resolve certain disciplinary matters through a voluntary pre-accusation settlement process. The author and a supporting pharmacist said it would speed resolution of smaller, technical cases and reduce costs, while a member raised concerns about transparency and whether the public would have less information about licensee misconduct. The bill passed the committee on a due-pass motion to Senate Appropriations, with Senator Menjivar voting no, and was placed on call. AB 2163, creating strategic clean energy and critical mineral development zones, was supported by the author and Imperial County as a way to prioritize geothermal and lithium development in areas like the Salton Sea region; it passed on a due-pass motion to Senate Appropriations and was placed on call. Later, AB 1990 on compounded weight-loss drug advertising drew significant debate. Supporters argued it would curb misleading ads and require disclosures about risks and non-FDA approval, while opponents from the compounding pharmacy community said it would create burdens, duplicate existing false-advertising law, and could harm patient access. Members questioned whether the bill actually addressed targeting minors and whether it would force use of FDA-approved labeling; the author said the bill was meant to add specificity and guardrails. The bill was moved on a due-pass motion to Senate Judiciary, with some no votes, and placed on call. The committee also heard AB 2783 on court reporters, which would add a national certification pathway and extend a remote reporting pilot; it drew support from court reporting stakeholders and passed unanimously on a due-pass motion to Senate Appropriations, placed on call. Finally, AB 2771, the Bureau for Private Postsecondary Education sunset bill, and AB 2772, the interior design certification sunset bill, were presented and heard with mixed testimony: AB 2771 received support from student and borrower advocates and was moved to Senate Education, while AB 2772 drew both support and strong opposition over CCIDC governance and accountability, with the committee hearing extensive public comment before the transcript ended.

Transcript Highlights:

• that, actually, if you're reporting disciplinary action, then other people like the State Board of Pharmacy

Bills: HB2947, HB2964, HB3143, HB3144, HB3342, HB3344, HB3519, HB3522, HB3530, HB3645, HB3647, HB3834, HB4300, HB4422, HB4423

Keywords: behavioral health, Medicaid expansion, clinical interns, mental health services, licensing requirements, medical records, patient rights, privacy, fees, healthcare access, legal claims, medical marijuana, license transfer, Oklahoma Medical Marijuana Authority, moratorium, business regulation, commercial grower licenses, licensing restrictions, agriculture, Medicaid

Bills: HB130, HB190, HB123, HB250, HB130, HB190, HB123, HB250

Keywords: HB130, Alabama Board of Licensure for Professional Geologists, Sunset Law, sunset review, licensure board, professional geologists, geology, geologist licensing, board appointments, congressional district representation, gubernatorial appointments, state boards and commissions, professional licensing, regulatory board, Alabama Code 34-41-4, environmental engineering, geotechnical engineering, mining industry, petroleum industry, geological sciences

Transcript Highlights:

• The bill would require the State Board of Pharmacy to adopt rules to this effect.
• Chair, I'm happy to take any questions, and we do have an invited witness from the State Board of Pharmacy
• Because we have the pharmacies tracking them, but because people get hooked on them and then they go
• on them, and they're not going to go away because opioids are a big problem. moneymaker for the pharmacies
• States already have this law in their state pharmacy policies and regulations requiring a warning label

Bills: HB136, HB451, SB425, SB466, SB905, SB1986, SB2311, SB2450, SB2805, SB2826, SB2919, SB3001, HB136

Keywords: Medicaid, lactation, healthcare, consultation, reimbursement, maternal health, infant care, commercial sexual exploitation, child sex trafficking, human trafficking, child welfare, foster care, DFPS, Department of Family and Protective Services, juvenile probation, risk assessment, needs assessment, trauma screening, child abuse prevention, exploitation screening